Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol

BACKGROUND: Nonarteritic anterior ischemic optic neuropathy (NAAION) is a major cause of blindness in individuals over 50 years of age, with no available effective treatment. The oral dual endothelin receptor antagonist, bosentan, increases retinal optic nerve head blood flow in healthy humans and g...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiquet, Christophe, Vignal, Catherine, Gohier, Philippe, Heron, Emmanuel, Thuret, Gilles, Rougier, Marie Bénédicte, Lehmann, Audrey, Flet, Laurent, Quesada, Jean-Louis, Roustit, Mathieu, Milea, Dan, Pepin, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617347/
https://www.ncbi.nlm.nih.gov/pubmed/36309759
http://dx.doi.org/10.1186/s13063-022-06786-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617347/
https://www.ncbi.nlm.nih.gov/pubmed/36309759
http://dx.doi.org/10.1186/s13063-022-06786-9

Ejemplares similares